Filter posts

ICYMI: Drug Development is Complicated. Let’s Start with the Facts.

Here’s a fact you might not have known: 90% of drug development programs fail. Yet …

RSV Vaccines

Respiratory syncytial virus (RSV) is a major pathogen in infants, children, and adults. According to …

The Journey from the Bench to Bedside

A partnership between a leading academic research center and a biologics company is aiming to …

Bridging Research to Cures: Summit for R&D Companies

As human and animal health companies struggle to advance medical innovation while managing costs, the …

Kansas City Area Summit Brings together CROs

The Kansas City region is home to 200 life science companies employing more than 20,000 …

Make Medical Research a National Priority

Biomedical and health research fuels private sector innovation and the development of new therapies and …

How to Survive the Patent Cliff: Eli Lilly’s CEO at the BIO CEO & Investor Conference

Like a number of companies, Eli Lilly is confronting a wave of patent expirations called …

Poster Session at BIO’s World Congress Showcases Cutting Edge Research

BIO’s 10th Annual World Congress on Industrial Biotechnology taking place this June in Montreal will feature …

Research: Working Together Toward Cures

Modern biomedical innovation and the discovery of new cures and therapies for devastating diseases require …

The Case of Misplaced Mountain Magnolias

Amidst the mountains of western North Carolina rests a stand of Sweetbay magnolia trees. This …